Keyphrases
Levonorgestrel
100%
Multi-centered
100%
Norplant
100%
Single Implant
100%
Implanon
100%
Risk Factors
70%
Indonesia
69%
Bleeding Pattern
50%
Antenatal Care Program
50%
Surabaya
50%
Hormonal Contraception
50%
Confidence Interval
50%
Maternal Mortality
50%
Meningioma
50%
Vaginal Bleeding
50%
Exposure Factors
50%
Odds Ratio
50%
Socioeconomic Background
50%
Contraceptives
30%
Amenorrhea
29%
Family Planning
26%
Bleeding Irregularities
23%
Bleeding
21%
Antenatal Care
20%
Continuation Rate
16%
Lost to Follow-up
16%
Non-medical Reasons
16%
Medical Reasoning
16%
Women Survivors
10%
Quality of Antenatal Care
10%
Multivariate Analysis
10%
Healthcare Facilities
10%
Antenatal Visits
10%
Toilet Facilities
10%
Maternal Death
10%
Case-control Design
10%
Low Socioeconomic Status
10%
Bivariate Analysis
10%
Referral Hospital
10%
Unemployment
10%
Subdermal Implant
8%
Subdermal
8%
Silastic Capsules
8%
Ethylene Vinyl Acetate
8%
Insertion Time
8%
Single Rod
8%
Removal Time
8%
Randomized Clinical Trial
8%
Period Analysis
7%
WHO Guidelines
7%
Medicine and Dentistry
Etonogestrel
100%
Levonorgestrel
100%
Implant
100%
Contraceptive Agent
55%
Meningioma
50%
Vagina Bleeding
50%
Bleeding
34%
Amenorrhea
22%
Spotting
16%
Gestagen
12%
Silastic
6%
Randomized Clinical Trial
6%
Subdermal Implant
6%
Ethylene Vinyl Acetate Copolymer
6%
Contraceptive Implant
6%
Family Planning
6%
Side Effect
6%
Intracranial Tumor
6%
Case-Control Study
6%
Clinical Trial
5%
Pharmacology, Toxicology and Pharmaceutical Science
Etonogestrel
100%
Levonorgestrel
100%
Implant
100%
Contraceptive Agent
55%
Meningioma
50%
Vagina Bleeding
50%
Bleeding
34%
Amenorrhea
22%
Spotting
16%
Progestin
12%
Ethylene Vinyl Acetate Copolymer
6%
Silastic
6%
Case-Control Study
6%
Side Effect
6%
Randomized Clinical Trial
6%
Intracranial Tumor
6%
Clinical Trial
5%